Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Application of Objective Visual Acuity Measurement Using Suppression Method to Inhibit Optokinetic Nystagmus (OKN).

NCT04642495 is registered in ClinicalTrials.gov with University of Basel as lead sponsor.

NCT NCT04642495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04642495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Application of Objective Visual Acuity Measurement Using Suppression Method to Inhibit Optokinetic Nystagmus (OKN).
Lead sponsor
University of Basel
Phase
Observational
Overall status
Completed
Start date
October 1, 2019
Completion date
September 30, 2020
Enrollment
246 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

visual acuity